At Motric Bio, we’re on a mission to improve the lives of people with muscle spasticity and enable them to gain function and freedom to actively enjoy life.

Our lead product candidate, MTR-601, represents a bold scientific advance that overcomes the challenges of selective targeting of myosin-2. In developing MTR-601 we have identified a single amino acid protein (L476), where the fast-twitch skeletal myosin-2 differs from all other myosin-2 isoforms in the body. Identifying this key variation enables MTR-601 to be rationally designed with a unique mechanism of action that specifically blocks fast-twitch skeletal muscle – without affecting cardiac and smooth muscle types.

Motric Bio

Org chart

Teams

Offices